Y. Z. Wang

发表

Potential use of the anti-inflammatory drug, sulfasalazine, for targeted therapy of pancreatic cancer.

C. Low, V. Ling, P. Gout, 2010, Current oncology.

The xc− cystine/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistance

Yuzhuo Wang, V. Ling, P. Gout, 2008, British Journal of Cancer.

Effect of the IkBα mutant gene delivery to mesenchymal stem cells on rat chronic pancreatitis.

T. Qin, F. Xue, C. Liu, 2014, Genetics and molecular research : GMR.

Comparing bacterial membrane interactions and antimicrobial activity of porcine lactoferricin-derived peptides.

Y. F. Liu, Y. Z. Wang, F. Han, 2013, Journal of dairy science.

Multidrug resistance activity in human lymphocytes.

J. Coon, A. Chong, H. Gebel, 1991, Human Immunology.

Suramin analogs inhibit human angiogenesis in vitro.

J. Su, E. Woltering, M. Meyers, 2000, The Journal of surgical research.

Colchicine and 2-methoxyestradiol Inhibit Human Angiogenesis.

E. Woltering, C. T. Anthony, J. Thomson, 2005, The Journal of surgical research.

Development and assessment of conventional and targeted drug combinations for use in the treatment of aggressive breast cancers.

D. Huntsman, K. Gelmon, S. Dedhar, 2006, Current cancer drug targets.

Investigation and comparison of the anti-tumor activities of lactoferrin, α-lactalbumin, and β-lactoglobulin in A549, HT29, HepG2, and MDA231-LM2 tumor models.

N. Zheng, Pingya Li, Huaigu Yang, 2019, Journal of dairy science.